P535 COVID-19 vaccine-induced neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 are diminished in patients with inflammatory bowel disease on anti-TNF or JAK-inhibitor therapy Article Swipe
Zhigang Liu
,
James L. Alexander
,
Kaixing Le
,
Xuhui Zhou
,
H Ibraheim
,
Sulak Anandabaskaran
,
Aamir Saifuddin
,
Kathy Weitung Lin
,
Leon R. McFarlane
,
Nikhil Anand
,
Laura Constable
,
Rocio Castro Seoane
,
Rachel Nice
,
Claire Bewshea
,
Andrea D’Mello
,
Gareth‐Rhys Jones
,
Sharmili Balarajah
,
Francesca Fiorentino
,
Shaji Sebastian
,
Peter M. Irving
,
L Hicks
,
H. J. Williams
,
Alexandra Kent
,
Rachel Linger
,
Miles Parkes
,
Klaartje Kok
,
Kamal Patel
,
Julian Teare
,
Daniel M. Altmann
,
A Hart
,
Charlie W. Lees
,
Rosemary J. Boyton
,
J Goodhand
,
Nicholas A. Kennedy
,
Katrina M. Pollock
,
Tahir Ahmad
,
Nick Powell
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1093/ecco-jcc/jjac190.0665
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1093/ecco-jcc/jjac190.0665
Background Patients with Inflammatory bowel disease (IBD) receiving anti-TNF or JAK-inhibitor therapy have attenuated responses to COVID-19 vaccination. We aimed to determine how IBD treatments affect neutralising antibody responses against the currently dominant Omicron BA.4/5 variants. Methods We prospectively recruited 329 adults (68 healthy controls (HC) and 261 IBD) who had received three doses of COVID-19 vaccine at nine UK centres. The IBD population was established (>12 weeks therapy) on either thiopurine (n=60), infliximab (IFX) (n=43), thiopurine & IFX combination (n=46), ustekinumab (n=43), vedolizumab (n=46) or tofacitinib (n=23). Pseudoneutralisation assays were performed and the half maximal inhibitory concentration (NT50) of participant sera was calculated. The primary outcome was anti-SARS-CoV-2 neutralising response against wild-type (WT) virus and the BA.4/5 variant after the second and third doses of anti-SARS-CoV-2 vaccine, stratified by immunosuppressive therapy, adjusting for prior infection, ethnicity, vaccine type and age. Results Heterologous (two doses adenovirus vaccine, third dose mRNA vaccine) and homologous (three doses mRNA vaccine) vaccination strategies significantly increased neutralising titres against both WT SARS-CoV-2 virus and the BA.4/5 variants in HCs and IBD (fig 1). Antibody titres against BA.4/5 were significantly lower than antibodies against WT virus in both groups (Geometric Mean Ratio (GMR) [95% CI], 0.11 [0.09, 0.15], P<0.0001 in healthy participants; GMR 0.07 [0.06, 0.08], P<0.0001 in IBD patients). Multivariable models showed that neutralising antibodies against BA.4/5 after three doses of vaccine were significantly lower in IBD patients on IFX (GMR 0.44 [0.20, 0.97], P=0.042), IFX and thiopurine combination (GMR 0.34 [0.15, 0.77], P=0.0098) or tofacitinib (GMR 0.37 [0.15, 0.92], P=0.032), but not in patients on thiopurine monotherapy, ustekinumab or vedolizumab. Breakthrough infection was associated with lower neutralising antibodies against WT and BA.4/5 (P<0.05). Conclusion A third dose of COVID-19 vaccine based on the WT spike glycoprotein boosts neutralising antibody titres in patients with IBD. However, responses are lower against the currently dominant variant BA.4/5, particularly in patients taking anti-TNF or JAK-inhibitor therapy. Breakthrough infections are associated with lower neutralising antibodies and immunosuppressed IBD patients may receive additional benefit from bivalent vaccine boosters which target Omicron variants. Financial support was provided as an Investigator Sponsored Research Grant from Pfizer Limited.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1093/ecco-jcc/jjac190.0665
- https://academic.oup.com/ecco-jcc/article-pdf/17/Supplement_1/i664/48954127/jjac190.0665.pdf
- OA Status
- bronze
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4318539903
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4318539903Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1093/ecco-jcc/jjac190.0665Digital Object Identifier
- Title
-
P535 COVID-19 vaccine-induced neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 are diminished in patients with inflammatory bowel disease on anti-TNF or JAK-inhibitor therapyWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-01-30Full publication date if available
- Authors
-
Zhigang Liu, James L. Alexander, Kaixing Le, Xuhui Zhou, H Ibraheim, Sulak Anandabaskaran, Aamir Saifuddin, Kathy Weitung Lin, Leon R. McFarlane, Nikhil Anand, Laura Constable, Rocio Castro Seoane, Rachel Nice, Claire Bewshea, Andrea D’Mello, Gareth‐Rhys Jones, Sharmili Balarajah, Francesca Fiorentino, Shaji Sebastian, Peter M. Irving, L Hicks, H. J. Williams, Alexandra Kent, Rachel Linger, Miles Parkes, Klaartje Kok, Kamal Patel, Julian Teare, Daniel M. Altmann, A Hart, Charlie W. Lees, Rosemary J. Boyton, J Goodhand, Nicholas A. Kennedy, Katrina M. Pollock, Tahir Ahmad, Nick PowellList of authors in order
- Landing page
-
https://doi.org/10.1093/ecco-jcc/jjac190.0665Publisher landing page
- PDF URL
-
https://academic.oup.com/ecco-jcc/article-pdf/17/Supplement_1/i664/48954127/jjac190.0665.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://academic.oup.com/ecco-jcc/article-pdf/17/Supplement_1/i664/48954127/jjac190.0665.pdfDirect OA link when available
- Concepts
-
Medicine, Inflammatory bowel disease, Vaccination, Infliximab, Antibody, Thiopurine methyltransferase, Immunology, Tofacitinib, Internal medicine, Gastroenterology, Population, Tumor necrosis factor alpha, Disease, Rheumatoid arthritis, Environmental healthTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4318539903 |
|---|---|
| doi | https://doi.org/10.1093/ecco-jcc/jjac190.0665 |
| ids.doi | https://doi.org/10.1093/ecco-jcc/jjac190.0665 |
| ids.openalex | https://openalex.org/W4318539903 |
| fwci | 0.0 |
| type | article |
| title | P535 COVID-19 vaccine-induced neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 are diminished in patients with inflammatory bowel disease on anti-TNF or JAK-inhibitor therapy |
| biblio.issue | Supplement_1 |
| biblio.volume | 17 |
| biblio.last_page | i664 |
| biblio.first_page | i664 |
| topics[0].id | https://openalex.org/T10118 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9997000098228455 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2725 |
| topics[0].subfield.display_name | Infectious Diseases |
| topics[0].display_name | SARS-CoV-2 and COVID-19 Research |
| topics[1].id | https://openalex.org/T10041 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9921000003814697 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2725 |
| topics[1].subfield.display_name | Infectious Diseases |
| topics[1].display_name | COVID-19 Clinical Research Studies |
| topics[2].id | https://openalex.org/T10158 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9905999898910522 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2730 |
| topics[2].subfield.display_name | Oncology |
| topics[2].display_name | Cancer Immunotherapy and Biomarkers |
| is_xpac | False |
| apc_list.value | 3881 |
| apc_list.currency | EUR |
| apc_list.value_usd | 4185 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.8896499276161194 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2778260677 |
| concepts[1].level | 3 |
| concepts[1].score | 0.6011189222335815 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q917447 |
| concepts[1].display_name | Inflammatory bowel disease |
| concepts[2].id | https://openalex.org/C22070199 |
| concepts[2].level | 2 |
| concepts[2].score | 0.565504252910614 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q192995 |
| concepts[2].display_name | Vaccination |
| concepts[3].id | https://openalex.org/C2777138892 |
| concepts[3].level | 3 |
| concepts[3].score | 0.5243632793426514 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q415264 |
| concepts[3].display_name | Infliximab |
| concepts[4].id | https://openalex.org/C159654299 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5130337476730347 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q79460 |
| concepts[4].display_name | Antibody |
| concepts[5].id | https://openalex.org/C70917649 |
| concepts[5].level | 4 |
| concepts[5].score | 0.5025804042816162 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q94307 |
| concepts[5].display_name | Thiopurine methyltransferase |
| concepts[6].id | https://openalex.org/C203014093 |
| concepts[6].level | 1 |
| concepts[6].score | 0.4675981402397156 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[6].display_name | Immunology |
| concepts[7].id | https://openalex.org/C2778886723 |
| concepts[7].level | 3 |
| concepts[7].score | 0.4556955397129059 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q3530324 |
| concepts[7].display_name | Tofacitinib |
| concepts[8].id | https://openalex.org/C126322002 |
| concepts[8].level | 1 |
| concepts[8].score | 0.437327116727829 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[8].display_name | Internal medicine |
| concepts[9].id | https://openalex.org/C90924648 |
| concepts[9].level | 1 |
| concepts[9].score | 0.42641186714172363 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q120569 |
| concepts[9].display_name | Gastroenterology |
| concepts[10].id | https://openalex.org/C2908647359 |
| concepts[10].level | 2 |
| concepts[10].score | 0.42344802618026733 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q2625603 |
| concepts[10].display_name | Population |
| concepts[11].id | https://openalex.org/C17991360 |
| concepts[11].level | 2 |
| concepts[11].score | 0.29869791865348816 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q21173843 |
| concepts[11].display_name | Tumor necrosis factor alpha |
| concepts[12].id | https://openalex.org/C2779134260 |
| concepts[12].level | 2 |
| concepts[12].score | 0.2012331783771515 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[12].display_name | Disease |
| concepts[13].id | https://openalex.org/C2777575956 |
| concepts[13].level | 2 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q187255 |
| concepts[13].display_name | Rheumatoid arthritis |
| concepts[14].id | https://openalex.org/C99454951 |
| concepts[14].level | 1 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q932068 |
| concepts[14].display_name | Environmental health |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.8896499276161194 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/inflammatory-bowel-disease |
| keywords[1].score | 0.6011189222335815 |
| keywords[1].display_name | Inflammatory bowel disease |
| keywords[2].id | https://openalex.org/keywords/vaccination |
| keywords[2].score | 0.565504252910614 |
| keywords[2].display_name | Vaccination |
| keywords[3].id | https://openalex.org/keywords/infliximab |
| keywords[3].score | 0.5243632793426514 |
| keywords[3].display_name | Infliximab |
| keywords[4].id | https://openalex.org/keywords/antibody |
| keywords[4].score | 0.5130337476730347 |
| keywords[4].display_name | Antibody |
| keywords[5].id | https://openalex.org/keywords/thiopurine-methyltransferase |
| keywords[5].score | 0.5025804042816162 |
| keywords[5].display_name | Thiopurine methyltransferase |
| keywords[6].id | https://openalex.org/keywords/immunology |
| keywords[6].score | 0.4675981402397156 |
| keywords[6].display_name | Immunology |
| keywords[7].id | https://openalex.org/keywords/tofacitinib |
| keywords[7].score | 0.4556955397129059 |
| keywords[7].display_name | Tofacitinib |
| keywords[8].id | https://openalex.org/keywords/internal-medicine |
| keywords[8].score | 0.437327116727829 |
| keywords[8].display_name | Internal medicine |
| keywords[9].id | https://openalex.org/keywords/gastroenterology |
| keywords[9].score | 0.42641186714172363 |
| keywords[9].display_name | Gastroenterology |
| keywords[10].id | https://openalex.org/keywords/population |
| keywords[10].score | 0.42344802618026733 |
| keywords[10].display_name | Population |
| keywords[11].id | https://openalex.org/keywords/tumor-necrosis-factor-alpha |
| keywords[11].score | 0.29869791865348816 |
| keywords[11].display_name | Tumor necrosis factor alpha |
| keywords[12].id | https://openalex.org/keywords/disease |
| keywords[12].score | 0.2012331783771515 |
| keywords[12].display_name | Disease |
| language | en |
| locations[0].id | doi:10.1093/ecco-jcc/jjac190.0665 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2735960814 |
| locations[0].source.issn | 1873-9946, 1876-4479 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1873-9946 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Journal of Crohn s and Colitis |
| locations[0].source.host_organization | https://openalex.org/P4310311648 |
| locations[0].source.host_organization_name | Oxford University Press |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310311648 |
| locations[0].license | |
| locations[0].pdf_url | https://academic.oup.com/ecco-jcc/article-pdf/17/Supplement_1/i664/48954127/jjac190.0665.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Journal of Crohn's and Colitis |
| locations[0].landing_page_url | https://doi.org/10.1093/ecco-jcc/jjac190.0665 |
| locations[1].id | pmh:oai:spiral.imperial.ac.uk:10044/1/102082 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306401396 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | Spiral (Imperial College London) |
| locations[1].source.host_organization | https://openalex.org/I47508984 |
| locations[1].source.host_organization_name | Imperial College London |
| locations[1].source.host_organization_lineage | https://openalex.org/I47508984 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Journal Article |
| locations[1].license_id | |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | i664 |
| locations[1].landing_page_url | http://hdl.handle.net/10044/1/102082 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5100398401 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-1363-6708 |
| authorships[0].author.display_name | Zhigang Liu |
| authorships[0].countries | GB |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I47508984 |
| authorships[0].affiliations[0].raw_affiliation_string | Imperial College London, Metabolism- Digestion & Reproduction , London, United Kingdom |
| authorships[0].institutions[0].id | https://openalex.org/I47508984 |
| authorships[0].institutions[0].ror | https://ror.org/041kmwe10 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I47508984 |
| authorships[0].institutions[0].country_code | GB |
| authorships[0].institutions[0].display_name | Imperial College London |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Z Liu |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Imperial College London, Metabolism- Digestion & Reproduction , London, United Kingdom |
| authorships[1].author.id | https://openalex.org/A5047051074 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-8542-327X |
| authorships[1].author.display_name | James L. Alexander |
| authorships[1].countries | GB |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I47508984 |
| authorships[1].affiliations[0].raw_affiliation_string | Imperial College London, Metabolism- Digestion & Reproduction , London, United Kingdom |
| authorships[1].institutions[0].id | https://openalex.org/I47508984 |
| authorships[1].institutions[0].ror | https://ror.org/041kmwe10 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I47508984 |
| authorships[1].institutions[0].country_code | GB |
| authorships[1].institutions[0].display_name | Imperial College London |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | J Alexander |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Imperial College London, Metabolism- Digestion & Reproduction , London, United Kingdom |
| authorships[2].author.id | https://openalex.org/A5112939675 |
| authorships[2].author.orcid | https://orcid.org/0009-0005-1092-8835 |
| authorships[2].author.display_name | Kaixing Le |
| authorships[2].countries | GB |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I47508984 |
| authorships[2].affiliations[0].raw_affiliation_string | Imperial College London, Metabolism- Digestion & Reproduction , London, United Kingdom |
| authorships[2].institutions[0].id | https://openalex.org/I47508984 |
| authorships[2].institutions[0].ror | https://ror.org/041kmwe10 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I47508984 |
| authorships[2].institutions[0].country_code | GB |
| authorships[2].institutions[0].display_name | Imperial College London |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | K Le |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Imperial College London, Metabolism- Digestion & Reproduction , London, United Kingdom |
| authorships[3].author.id | https://openalex.org/A5042267180 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-1033-9940 |
| authorships[3].author.display_name | Xuhui Zhou |
| authorships[3].countries | GB |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I47508984 |
| authorships[3].affiliations[0].raw_affiliation_string | Imperial College London, Metabolism- Digestion & Reproduction , London, United Kingdom |
| authorships[3].institutions[0].id | https://openalex.org/I47508984 |
| authorships[3].institutions[0].ror | https://ror.org/041kmwe10 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I47508984 |
| authorships[3].institutions[0].country_code | GB |
| authorships[3].institutions[0].display_name | Imperial College London |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | X Zhou |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Imperial College London, Metabolism- Digestion & Reproduction , London, United Kingdom |
| authorships[4].author.id | https://openalex.org/A5013617362 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | H Ibraheim |
| authorships[4].countries | GB |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I47508984 |
| authorships[4].affiliations[0].raw_affiliation_string | Imperial College London, Metabolism- Digestion & Reproduction , London, United Kingdom |
| authorships[4].institutions[0].id | https://openalex.org/I47508984 |
| authorships[4].institutions[0].ror | https://ror.org/041kmwe10 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I47508984 |
| authorships[4].institutions[0].country_code | GB |
| authorships[4].institutions[0].display_name | Imperial College London |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | H Ibraheim |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Imperial College London, Metabolism- Digestion & Reproduction , London, United Kingdom |
| authorships[5].author.id | https://openalex.org/A5087258039 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Sulak Anandabaskaran |
| authorships[5].countries | GB |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I47508984 |
| authorships[5].affiliations[0].raw_affiliation_string | Imperial College London, Metabolism- Digestion & Reproduction , London, United Kingdom |
| authorships[5].institutions[0].id | https://openalex.org/I47508984 |
| authorships[5].institutions[0].ror | https://ror.org/041kmwe10 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I47508984 |
| authorships[5].institutions[0].country_code | GB |
| authorships[5].institutions[0].display_name | Imperial College London |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | S Anandabaskaran |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Imperial College London, Metabolism- Digestion & Reproduction , London, United Kingdom |
| authorships[6].author.id | https://openalex.org/A5078518078 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-5888-5556 |
| authorships[6].author.display_name | Aamir Saifuddin |
| authorships[6].countries | GB |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I47508984 |
| authorships[6].affiliations[0].raw_affiliation_string | Imperial College London, Metabolism- Digestion & Reproduction , London, United Kingdom |
| authorships[6].institutions[0].id | https://openalex.org/I47508984 |
| authorships[6].institutions[0].ror | https://ror.org/041kmwe10 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I47508984 |
| authorships[6].institutions[0].country_code | GB |
| authorships[6].institutions[0].display_name | Imperial College London |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | A Saifuddin |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Imperial College London, Metabolism- Digestion & Reproduction , London, United Kingdom |
| authorships[7].author.id | https://openalex.org/A5071612494 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Kathy Weitung Lin |
| authorships[7].countries | GB |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I47508984 |
| authorships[7].affiliations[0].raw_affiliation_string | Imperial College London, Infectious Diseases , London, United Kingdom |
| authorships[7].institutions[0].id | https://openalex.org/I47508984 |
| authorships[7].institutions[0].ror | https://ror.org/041kmwe10 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I47508984 |
| authorships[7].institutions[0].country_code | GB |
| authorships[7].institutions[0].display_name | Imperial College London |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | K Lin |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Imperial College London, Infectious Diseases , London, United Kingdom |
| authorships[8].author.id | https://openalex.org/A5004237235 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-7982-1682 |
| authorships[8].author.display_name | Leon R. McFarlane |
| authorships[8].countries | GB |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I47508984 |
| authorships[8].affiliations[0].raw_affiliation_string | Imperial College London, Infectious Diseases , London, United Kingdom |
| authorships[8].institutions[0].id | https://openalex.org/I47508984 |
| authorships[8].institutions[0].ror | https://ror.org/041kmwe10 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I47508984 |
| authorships[8].institutions[0].country_code | GB |
| authorships[8].institutions[0].display_name | Imperial College London |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | L Mcfarlane |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Imperial College London, Infectious Diseases , London, United Kingdom |
| authorships[9].author.id | https://openalex.org/A5087050607 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-2670-2145 |
| authorships[9].author.display_name | Nikhil Anand |
| authorships[9].countries | GB |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I47508984 |
| authorships[9].affiliations[0].raw_affiliation_string | Imperial College London, Metabolism- Digestion & Reproduction , London, United Kingdom |
| authorships[9].institutions[0].id | https://openalex.org/I47508984 |
| authorships[9].institutions[0].ror | https://ror.org/041kmwe10 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I47508984 |
| authorships[9].institutions[0].country_code | GB |
| authorships[9].institutions[0].display_name | Imperial College London |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | N Anand |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Imperial College London, Metabolism- Digestion & Reproduction , London, United Kingdom |
| authorships[10].author.id | https://openalex.org/A5058358458 |
| authorships[10].author.orcid | https://orcid.org/0000-0003-1043-9888 |
| authorships[10].author.display_name | Laura Constable |
| authorships[10].countries | GB |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I47508984 |
| authorships[10].affiliations[0].raw_affiliation_string | Imperial College London, Metabolism- Digestion & Reproduction , London, United Kingdom |
| authorships[10].institutions[0].id | https://openalex.org/I47508984 |
| authorships[10].institutions[0].ror | https://ror.org/041kmwe10 |
| authorships[10].institutions[0].type | education |
| authorships[10].institutions[0].lineage | https://openalex.org/I47508984 |
| authorships[10].institutions[0].country_code | GB |
| authorships[10].institutions[0].display_name | Imperial College London |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | L Constable |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Imperial College London, Metabolism- Digestion & Reproduction , London, United Kingdom |
| authorships[11].author.id | https://openalex.org/A5101611899 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-2938-3872 |
| authorships[11].author.display_name | Rocio Castro Seoane |
| authorships[11].countries | GB |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I47508984 |
| authorships[11].affiliations[0].raw_affiliation_string | Imperial College London, Metabolism- Digestion & Reproduction , London, United Kingdom |
| authorships[11].institutions[0].id | https://openalex.org/I47508984 |
| authorships[11].institutions[0].ror | https://ror.org/041kmwe10 |
| authorships[11].institutions[0].type | education |
| authorships[11].institutions[0].lineage | https://openalex.org/I47508984 |
| authorships[11].institutions[0].country_code | GB |
| authorships[11].institutions[0].display_name | Imperial College London |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | R Castro-Seoane |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Imperial College London, Metabolism- Digestion & Reproduction , London, United Kingdom |
| authorships[12].author.id | https://openalex.org/A5108825887 |
| authorships[12].author.orcid | |
| authorships[12].author.display_name | Rachel Nice |
| authorships[12].countries | GB |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I23923803 |
| authorships[12].affiliations[0].raw_affiliation_string | University of Exeter, Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group , Exeter, United Kingdom |
| authorships[12].institutions[0].id | https://openalex.org/I23923803 |
| authorships[12].institutions[0].ror | https://ror.org/03yghzc09 |
| authorships[12].institutions[0].type | education |
| authorships[12].institutions[0].lineage | https://openalex.org/I23923803 |
| authorships[12].institutions[0].country_code | GB |
| authorships[12].institutions[0].display_name | University of Exeter |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | R Nice |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | University of Exeter, Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group , Exeter, United Kingdom |
| authorships[13].author.id | https://openalex.org/A5069238850 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-0965-9587 |
| authorships[13].author.display_name | Claire Bewshea |
| authorships[13].countries | GB |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I23923803 |
| authorships[13].affiliations[0].raw_affiliation_string | University of Exeter, Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group , Exeter, United Kingdom |
| authorships[13].institutions[0].id | https://openalex.org/I23923803 |
| authorships[13].institutions[0].ror | https://ror.org/03yghzc09 |
| authorships[13].institutions[0].type | education |
| authorships[13].institutions[0].lineage | https://openalex.org/I23923803 |
| authorships[13].institutions[0].country_code | GB |
| authorships[13].institutions[0].display_name | University of Exeter |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | C Bewshea |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | University of Exeter, Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group , Exeter, United Kingdom |
| authorships[14].author.id | https://openalex.org/A5079778096 |
| authorships[14].author.orcid | |
| authorships[14].author.display_name | Andrea D’Mello |
| authorships[14].countries | GB |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I153355300 |
| authorships[14].affiliations[0].raw_affiliation_string | Imperial College Healthcare NHS Trust, Medicine & Integrated Care , London, United Kingdom |
| authorships[14].institutions[0].id | https://openalex.org/I153355300 |
| authorships[14].institutions[0].ror | https://ror.org/056ffv270 |
| authorships[14].institutions[0].type | healthcare |
| authorships[14].institutions[0].lineage | https://openalex.org/I153355300 |
| authorships[14].institutions[0].country_code | GB |
| authorships[14].institutions[0].display_name | Imperial College Healthcare NHS Trust |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | A D'Mello |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Imperial College Healthcare NHS Trust, Medicine & Integrated Care , London, United Kingdom |
| authorships[15].author.id | https://openalex.org/A5026906368 |
| authorships[15].author.orcid | https://orcid.org/0000-0001-7355-2357 |
| authorships[15].author.display_name | Gareth‐Rhys Jones |
| authorships[15].countries | GB |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I4210151647, https://openalex.org/I98677209 |
| authorships[15].affiliations[0].raw_affiliation_string | University of Edinburgh, Centre for Inflammation Research , Edinburgh, United Kingdom |
| authorships[15].institutions[0].id | https://openalex.org/I4210151647 |
| authorships[15].institutions[0].ror | https://ror.org/05wcr1b38 |
| authorships[15].institutions[0].type | facility |
| authorships[15].institutions[0].lineage | https://openalex.org/I4210087105, https://openalex.org/I4210151647, https://openalex.org/I90344618, https://openalex.org/I98677209 |
| authorships[15].institutions[0].country_code | GB |
| authorships[15].institutions[0].display_name | Centre for Inflammation Research |
| authorships[15].institutions[1].id | https://openalex.org/I98677209 |
| authorships[15].institutions[1].ror | https://ror.org/01nrxwf90 |
| authorships[15].institutions[1].type | education |
| authorships[15].institutions[1].lineage | https://openalex.org/I98677209 |
| authorships[15].institutions[1].country_code | GB |
| authorships[15].institutions[1].display_name | University of Edinburgh |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | G R Jones |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | University of Edinburgh, Centre for Inflammation Research , Edinburgh, United Kingdom |
| authorships[16].author.id | https://openalex.org/A5032971128 |
| authorships[16].author.orcid | https://orcid.org/0000-0003-0229-8528 |
| authorships[16].author.display_name | Sharmili Balarajah |
| authorships[16].countries | GB |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I47508984 |
| authorships[16].affiliations[0].raw_affiliation_string | Imperial College London, Metabolism- Digestion & Reproduction , London, United Kingdom |
| authorships[16].institutions[0].id | https://openalex.org/I47508984 |
| authorships[16].institutions[0].ror | https://ror.org/041kmwe10 |
| authorships[16].institutions[0].type | education |
| authorships[16].institutions[0].lineage | https://openalex.org/I47508984 |
| authorships[16].institutions[0].country_code | GB |
| authorships[16].institutions[0].display_name | Imperial College London |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | S Balarajah |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Imperial College London, Metabolism- Digestion & Reproduction , London, United Kingdom |
| authorships[17].author.id | https://openalex.org/A5026927527 |
| authorships[17].author.orcid | https://orcid.org/0000-0001-9817-6634 |
| authorships[17].author.display_name | Francesca Fiorentino |
| authorships[17].countries | GB |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I183935753 |
| authorships[17].affiliations[0].raw_affiliation_string | King's College London, Nightingale-Saunders Clinical Trials & Epidemiology Unit King's Clinical Trials Unit , London, United Kingdom |
| authorships[17].institutions[0].id | https://openalex.org/I183935753 |
| authorships[17].institutions[0].ror | https://ror.org/0220mzb33 |
| authorships[17].institutions[0].type | education |
| authorships[17].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I183935753 |
| authorships[17].institutions[0].country_code | GB |
| authorships[17].institutions[0].display_name | King's College London |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | F Fiorentino |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | King's College London, Nightingale-Saunders Clinical Trials & Epidemiology Unit King's Clinical Trials Unit , London, United Kingdom |
| authorships[18].author.id | https://openalex.org/A5046490863 |
| authorships[18].author.orcid | https://orcid.org/0000-0002-3670-6545 |
| authorships[18].author.display_name | Shaji Sebastian |
| authorships[18].countries | GB |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I191240316 |
| authorships[18].affiliations[0].raw_affiliation_string | Hull University Teaching Hospitals NHS Trust, Gastroenterology , Hull, United Kingdom |
| authorships[18].institutions[0].id | https://openalex.org/I191240316 |
| authorships[18].institutions[0].ror | https://ror.org/04nkhwh30 |
| authorships[18].institutions[0].type | education |
| authorships[18].institutions[0].lineage | https://openalex.org/I191240316 |
| authorships[18].institutions[0].country_code | GB |
| authorships[18].institutions[0].display_name | University of Hull |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | S Sebastian |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | Hull University Teaching Hospitals NHS Trust, Gastroenterology , Hull, United Kingdom |
| authorships[19].author.id | https://openalex.org/A5031136418 |
| authorships[19].author.orcid | https://orcid.org/0000-0003-0972-8148 |
| authorships[19].author.display_name | Peter M. Irving |
| authorships[19].countries | GB |
| authorships[19].affiliations[0].institution_ids | https://openalex.org/I183935753 |
| authorships[19].affiliations[0].raw_affiliation_string | King's College London, School of Immunology & Microbial Sciences , London, United Kingdom |
| authorships[19].institutions[0].id | https://openalex.org/I183935753 |
| authorships[19].institutions[0].ror | https://ror.org/0220mzb33 |
| authorships[19].institutions[0].type | education |
| authorships[19].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I183935753 |
| authorships[19].institutions[0].country_code | GB |
| authorships[19].institutions[0].display_name | King's College London |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | P Irving |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | King's College London, School of Immunology & Microbial Sciences , London, United Kingdom |
| authorships[20].author.id | https://openalex.org/A5114052897 |
| authorships[20].author.orcid | |
| authorships[20].author.display_name | L Hicks |
| authorships[20].countries | GB |
| authorships[20].affiliations[0].institution_ids | https://openalex.org/I47508984 |
| authorships[20].affiliations[0].raw_affiliation_string | Imperial College London, Metabolism- Digestion & Reproduction , London, United Kingdom |
| authorships[20].institutions[0].id | https://openalex.org/I47508984 |
| authorships[20].institutions[0].ror | https://ror.org/041kmwe10 |
| authorships[20].institutions[0].type | education |
| authorships[20].institutions[0].lineage | https://openalex.org/I47508984 |
| authorships[20].institutions[0].country_code | GB |
| authorships[20].institutions[0].display_name | Imperial College London |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | L Hicks |
| authorships[20].is_corresponding | False |
| authorships[20].raw_affiliation_strings | Imperial College London, Metabolism- Digestion & Reproduction , London, United Kingdom |
| authorships[21].author.id | https://openalex.org/A5013230828 |
| authorships[21].author.orcid | https://orcid.org/0000-0001-8356-8539 |
| authorships[21].author.display_name | H. J. Williams |
| authorships[21].countries | GB |
| authorships[21].affiliations[0].institution_ids | https://openalex.org/I47508984 |
| authorships[21].affiliations[0].raw_affiliation_string | Imperial College London, Metabolism- Digestion & Reproduction , London, United Kingdom |
| authorships[21].institutions[0].id | https://openalex.org/I47508984 |
| authorships[21].institutions[0].ror | https://ror.org/041kmwe10 |
| authorships[21].institutions[0].type | education |
| authorships[21].institutions[0].lineage | https://openalex.org/I47508984 |
| authorships[21].institutions[0].country_code | GB |
| authorships[21].institutions[0].display_name | Imperial College London |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | H Williams |
| authorships[21].is_corresponding | False |
| authorships[21].raw_affiliation_strings | Imperial College London, Metabolism- Digestion & Reproduction , London, United Kingdom |
| authorships[22].author.id | https://openalex.org/A5073394928 |
| authorships[22].author.orcid | https://orcid.org/0000-0003-0577-6177 |
| authorships[22].author.display_name | Alexandra Kent |
| authorships[22].countries | GB |
| authorships[22].affiliations[0].institution_ids | https://openalex.org/I4210153400 |
| authorships[22].affiliations[0].raw_affiliation_string | King's College Hospital, Gastroenterology , London, United Kingdom |
| authorships[22].institutions[0].id | https://openalex.org/I4210153400 |
| authorships[22].institutions[0].ror | https://ror.org/044nptt90 |
| authorships[22].institutions[0].type | healthcare |
| authorships[22].institutions[0].lineage | https://openalex.org/I4210111135, https://openalex.org/I4210153400 |
| authorships[22].institutions[0].country_code | GB |
| authorships[22].institutions[0].display_name | King's College Hospital |
| authorships[22].author_position | middle |
| authorships[22].raw_author_name | A Kent |
| authorships[22].is_corresponding | False |
| authorships[22].raw_affiliation_strings | King's College Hospital, Gastroenterology , London, United Kingdom |
| authorships[23].author.id | https://openalex.org/A5110527130 |
| authorships[23].author.orcid | |
| authorships[23].author.display_name | Rachel Linger |
| authorships[23].countries | GB |
| authorships[23].affiliations[0].institution_ids | https://openalex.org/I241749 |
| authorships[23].affiliations[0].raw_affiliation_string | University of Cambridge, The NIHR Bioresource , Cambridge, United Kingdom |
| authorships[23].institutions[0].id | https://openalex.org/I241749 |
| authorships[23].institutions[0].ror | https://ror.org/013meh722 |
| authorships[23].institutions[0].type | education |
| authorships[23].institutions[0].lineage | https://openalex.org/I241749 |
| authorships[23].institutions[0].country_code | GB |
| authorships[23].institutions[0].display_name | University of Cambridge |
| authorships[23].author_position | middle |
| authorships[23].raw_author_name | R Linger |
| authorships[23].is_corresponding | False |
| authorships[23].raw_affiliation_strings | University of Cambridge, The NIHR Bioresource , Cambridge, United Kingdom |
| authorships[24].author.id | https://openalex.org/A5066218040 |
| authorships[24].author.orcid | https://orcid.org/0000-0002-6467-0631 |
| authorships[24].author.display_name | Miles Parkes |
| authorships[24].countries | GB |
| authorships[24].affiliations[0].institution_ids | https://openalex.org/I241749 |
| authorships[24].affiliations[0].raw_affiliation_string | University of Cambridge, Gastroenterology , Cambridge, United Kingdom |
| authorships[24].institutions[0].id | https://openalex.org/I241749 |
| authorships[24].institutions[0].ror | https://ror.org/013meh722 |
| authorships[24].institutions[0].type | education |
| authorships[24].institutions[0].lineage | https://openalex.org/I241749 |
| authorships[24].institutions[0].country_code | GB |
| authorships[24].institutions[0].display_name | University of Cambridge |
| authorships[24].author_position | middle |
| authorships[24].raw_author_name | M Parkes |
| authorships[24].is_corresponding | False |
| authorships[24].raw_affiliation_strings | University of Cambridge, Gastroenterology , Cambridge, United Kingdom |
| authorships[25].author.id | https://openalex.org/A5043915683 |
| authorships[25].author.orcid | https://orcid.org/0000-0002-5942-9149 |
| authorships[25].author.display_name | Klaartje Kok |
| authorships[25].countries | GB |
| authorships[25].affiliations[0].institution_ids | https://openalex.org/I225661044 |
| authorships[25].affiliations[0].raw_affiliation_string | Bart's Health NHS Trust, Gastroenterology , London, United Kingdom |
| authorships[25].institutions[0].id | https://openalex.org/I225661044 |
| authorships[25].institutions[0].ror | https://ror.org/00b31g692 |
| authorships[25].institutions[0].type | healthcare |
| authorships[25].institutions[0].lineage | https://openalex.org/I225661044 |
| authorships[25].institutions[0].country_code | GB |
| authorships[25].institutions[0].display_name | Barts Health NHS Trust |
| authorships[25].author_position | middle |
| authorships[25].raw_author_name | K Kok |
| authorships[25].is_corresponding | False |
| authorships[25].raw_affiliation_strings | Bart's Health NHS Trust, Gastroenterology , London, United Kingdom |
| authorships[26].author.id | https://openalex.org/A5037680180 |
| authorships[26].author.orcid | https://orcid.org/0000-0003-2611-4260 |
| authorships[26].author.display_name | Kamal Patel |
| authorships[26].countries | GB |
| authorships[26].affiliations[0].institution_ids | https://openalex.org/I4210113489 |
| authorships[26].affiliations[0].raw_affiliation_string | St George's Hospital NHS Trust, Gastroenterology , London, United Kingdom |
| authorships[26].institutions[0].id | https://openalex.org/I4210113489 |
| authorships[26].institutions[0].ror | https://ror.org/02507sy82 |
| authorships[26].institutions[0].type | healthcare |
| authorships[26].institutions[0].lineage | https://openalex.org/I4210111466, https://openalex.org/I4210113489 |
| authorships[26].institutions[0].country_code | GB |
| authorships[26].institutions[0].display_name | St George's Hospital |
| authorships[26].author_position | middle |
| authorships[26].raw_author_name | K V Patel |
| authorships[26].is_corresponding | False |
| authorships[26].raw_affiliation_strings | St George's Hospital NHS Trust, Gastroenterology , London, United Kingdom |
| authorships[27].author.id | https://openalex.org/A5001255955 |
| authorships[27].author.orcid | https://orcid.org/0000-0003-3551-9139 |
| authorships[27].author.display_name | Julian Teare |
| authorships[27].countries | GB |
| authorships[27].affiliations[0].institution_ids | https://openalex.org/I47508984 |
| authorships[27].affiliations[0].raw_affiliation_string | Imperial College London, Surgery & Cancer , London, United Kingdom |
| authorships[27].institutions[0].id | https://openalex.org/I47508984 |
| authorships[27].institutions[0].ror | https://ror.org/041kmwe10 |
| authorships[27].institutions[0].type | education |
| authorships[27].institutions[0].lineage | https://openalex.org/I47508984 |
| authorships[27].institutions[0].country_code | GB |
| authorships[27].institutions[0].display_name | Imperial College London |
| authorships[27].author_position | middle |
| authorships[27].raw_author_name | J Teare |
| authorships[27].is_corresponding | False |
| authorships[27].raw_affiliation_strings | Imperial College London, Surgery & Cancer , London, United Kingdom |
| authorships[28].author.id | https://openalex.org/A5009753247 |
| authorships[28].author.orcid | https://orcid.org/0000-0002-2436-6192 |
| authorships[28].author.display_name | Daniel M. Altmann |
| authorships[28].countries | GB |
| authorships[28].affiliations[0].institution_ids | https://openalex.org/I47508984 |
| authorships[28].affiliations[0].raw_affiliation_string | Imperial College London, Immunology and Inflammation , London, United Kingdom |
| authorships[28].institutions[0].id | https://openalex.org/I47508984 |
| authorships[28].institutions[0].ror | https://ror.org/041kmwe10 |
| authorships[28].institutions[0].type | education |
| authorships[28].institutions[0].lineage | https://openalex.org/I47508984 |
| authorships[28].institutions[0].country_code | GB |
| authorships[28].institutions[0].display_name | Imperial College London |
| authorships[28].author_position | middle |
| authorships[28].raw_author_name | D Altmann |
| authorships[28].is_corresponding | False |
| authorships[28].raw_affiliation_strings | Imperial College London, Immunology and Inflammation , London, United Kingdom |
| authorships[29].author.id | https://openalex.org/A5103186138 |
| authorships[29].author.orcid | https://orcid.org/0000-0001-9912-3323 |
| authorships[29].author.display_name | A Hart |
| authorships[29].countries | GB |
| authorships[29].affiliations[0].institution_ids | https://openalex.org/I4210161740 |
| authorships[29].affiliations[0].raw_affiliation_string | St Mark's Academic Institute, Gastroenterology , London, United Kingdom |
| authorships[29].institutions[0].id | https://openalex.org/I4210161740 |
| authorships[29].institutions[0].ror | https://ror.org/05am5g719 |
| authorships[29].institutions[0].type | healthcare |
| authorships[29].institutions[0].lineage | https://openalex.org/I2800484787, https://openalex.org/I4210161740 |
| authorships[29].institutions[0].country_code | GB |
| authorships[29].institutions[0].display_name | St Mark's Hospital |
| authorships[29].author_position | middle |
| authorships[29].raw_author_name | A Hart |
| authorships[29].is_corresponding | False |
| authorships[29].raw_affiliation_strings | St Mark's Academic Institute, Gastroenterology , London, United Kingdom |
| authorships[30].author.id | https://openalex.org/A5078976339 |
| authorships[30].author.orcid | https://orcid.org/0000-0002-0732-8215 |
| authorships[30].author.display_name | Charlie W. Lees |
| authorships[30].countries | GB |
| authorships[30].affiliations[0].institution_ids | https://openalex.org/I4210151647, https://openalex.org/I98677209 |
| authorships[30].affiliations[0].raw_affiliation_string | University of Edinburgh, Centre for Inflammation Research , Edinburgh, United Kingdom |
| authorships[30].institutions[0].id | https://openalex.org/I4210151647 |
| authorships[30].institutions[0].ror | https://ror.org/05wcr1b38 |
| authorships[30].institutions[0].type | facility |
| authorships[30].institutions[0].lineage | https://openalex.org/I4210087105, https://openalex.org/I4210151647, https://openalex.org/I90344618, https://openalex.org/I98677209 |
| authorships[30].institutions[0].country_code | GB |
| authorships[30].institutions[0].display_name | Centre for Inflammation Research |
| authorships[30].institutions[1].id | https://openalex.org/I98677209 |
| authorships[30].institutions[1].ror | https://ror.org/01nrxwf90 |
| authorships[30].institutions[1].type | education |
| authorships[30].institutions[1].lineage | https://openalex.org/I98677209 |
| authorships[30].institutions[1].country_code | GB |
| authorships[30].institutions[1].display_name | University of Edinburgh |
| authorships[30].author_position | middle |
| authorships[30].raw_author_name | C Lees |
| authorships[30].is_corresponding | False |
| authorships[30].raw_affiliation_strings | University of Edinburgh, Centre for Inflammation Research , Edinburgh, United Kingdom |
| authorships[31].author.id | https://openalex.org/A5009824484 |
| authorships[31].author.orcid | https://orcid.org/0000-0002-5608-0797 |
| authorships[31].author.display_name | Rosemary J. Boyton |
| authorships[31].countries | GB |
| authorships[31].affiliations[0].institution_ids | https://openalex.org/I47508984 |
| authorships[31].affiliations[0].raw_affiliation_string | Imperial College London, Immunology and Inflammation , London, United Kingdom |
| authorships[31].institutions[0].id | https://openalex.org/I47508984 |
| authorships[31].institutions[0].ror | https://ror.org/041kmwe10 |
| authorships[31].institutions[0].type | education |
| authorships[31].institutions[0].lineage | https://openalex.org/I47508984 |
| authorships[31].institutions[0].country_code | GB |
| authorships[31].institutions[0].display_name | Imperial College London |
| authorships[31].author_position | middle |
| authorships[31].raw_author_name | R Boyton |
| authorships[31].is_corresponding | False |
| authorships[31].raw_affiliation_strings | Imperial College London, Immunology and Inflammation , London, United Kingdom |
| authorships[32].author.id | https://openalex.org/A5014969056 |
| authorships[32].author.orcid | |
| authorships[32].author.display_name | J Goodhand |
| authorships[32].countries | GB |
| authorships[32].affiliations[0].institution_ids | https://openalex.org/I23923803 |
| authorships[32].affiliations[0].raw_affiliation_string | University of Exeter, Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group , Exeter, United Kingdom |
| authorships[32].institutions[0].id | https://openalex.org/I23923803 |
| authorships[32].institutions[0].ror | https://ror.org/03yghzc09 |
| authorships[32].institutions[0].type | education |
| authorships[32].institutions[0].lineage | https://openalex.org/I23923803 |
| authorships[32].institutions[0].country_code | GB |
| authorships[32].institutions[0].display_name | University of Exeter |
| authorships[32].author_position | middle |
| authorships[32].raw_author_name | J Goodhand |
| authorships[32].is_corresponding | False |
| authorships[32].raw_affiliation_strings | University of Exeter, Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group , Exeter, United Kingdom |
| authorships[33].author.id | https://openalex.org/A5047522708 |
| authorships[33].author.orcid | https://orcid.org/0000-0003-4368-1961 |
| authorships[33].author.display_name | Nicholas A. Kennedy |
| authorships[33].countries | GB |
| authorships[33].affiliations[0].institution_ids | https://openalex.org/I23923803 |
| authorships[33].affiliations[0].raw_affiliation_string | University of Exeter, Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group , Exeter, United Kingdom |
| authorships[33].institutions[0].id | https://openalex.org/I23923803 |
| authorships[33].institutions[0].ror | https://ror.org/03yghzc09 |
| authorships[33].institutions[0].type | education |
| authorships[33].institutions[0].lineage | https://openalex.org/I23923803 |
| authorships[33].institutions[0].country_code | GB |
| authorships[33].institutions[0].display_name | University of Exeter |
| authorships[33].author_position | middle |
| authorships[33].raw_author_name | N Kennedy |
| authorships[33].is_corresponding | False |
| authorships[33].raw_affiliation_strings | University of Exeter, Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group , Exeter, United Kingdom |
| authorships[34].author.id | https://openalex.org/A5077353929 |
| authorships[34].author.orcid | https://orcid.org/0000-0001-9513-5183 |
| authorships[34].author.display_name | Katrina M. Pollock |
| authorships[34].countries | GB |
| authorships[34].affiliations[0].institution_ids | https://openalex.org/I47508984 |
| authorships[34].affiliations[0].raw_affiliation_string | Imperial College London, Infectious Diseases , London, United Kingdom |
| authorships[34].institutions[0].id | https://openalex.org/I47508984 |
| authorships[34].institutions[0].ror | https://ror.org/041kmwe10 |
| authorships[34].institutions[0].type | education |
| authorships[34].institutions[0].lineage | https://openalex.org/I47508984 |
| authorships[34].institutions[0].country_code | GB |
| authorships[34].institutions[0].display_name | Imperial College London |
| authorships[34].author_position | middle |
| authorships[34].raw_author_name | K Pollock |
| authorships[34].is_corresponding | False |
| authorships[34].raw_affiliation_strings | Imperial College London, Infectious Diseases , London, United Kingdom |
| authorships[35].author.id | https://openalex.org/A5031491714 |
| authorships[35].author.orcid | https://orcid.org/0000-0003-2650-6950 |
| authorships[35].author.display_name | Tahir Ahmad |
| authorships[35].countries | GB |
| authorships[35].affiliations[0].institution_ids | https://openalex.org/I23923803 |
| authorships[35].affiliations[0].raw_affiliation_string | University of Exeter, Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group , Exeter, United Kingdom |
| authorships[35].institutions[0].id | https://openalex.org/I23923803 |
| authorships[35].institutions[0].ror | https://ror.org/03yghzc09 |
| authorships[35].institutions[0].type | education |
| authorships[35].institutions[0].lineage | https://openalex.org/I23923803 |
| authorships[35].institutions[0].country_code | GB |
| authorships[35].institutions[0].display_name | University of Exeter |
| authorships[35].author_position | middle |
| authorships[35].raw_author_name | T Ahmad |
| authorships[35].is_corresponding | False |
| authorships[35].raw_affiliation_strings | University of Exeter, Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group , Exeter, United Kingdom |
| authorships[36].author.id | https://openalex.org/A5059369253 |
| authorships[36].author.orcid | https://orcid.org/0000-0003-3231-6950 |
| authorships[36].author.display_name | Nick Powell |
| authorships[36].countries | GB |
| authorships[36].affiliations[0].institution_ids | https://openalex.org/I47508984 |
| authorships[36].affiliations[0].raw_affiliation_string | Imperial College London, Metabolism- Digestion & Reproduction , London, United Kingdom |
| authorships[36].institutions[0].id | https://openalex.org/I47508984 |
| authorships[36].institutions[0].ror | https://ror.org/041kmwe10 |
| authorships[36].institutions[0].type | education |
| authorships[36].institutions[0].lineage | https://openalex.org/I47508984 |
| authorships[36].institutions[0].country_code | GB |
| authorships[36].institutions[0].display_name | Imperial College London |
| authorships[36].author_position | last |
| authorships[36].raw_author_name | N Powell |
| authorships[36].is_corresponding | False |
| authorships[36].raw_affiliation_strings | Imperial College London, Metabolism- Digestion & Reproduction , London, United Kingdom |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://academic.oup.com/ecco-jcc/article-pdf/17/Supplement_1/i664/48954127/jjac190.0665.pdf |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | P535 COVID-19 vaccine-induced neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 are diminished in patients with inflammatory bowel disease on anti-TNF or JAK-inhibitor therapy |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10118 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9997000098228455 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2725 |
| primary_topic.subfield.display_name | Infectious Diseases |
| primary_topic.display_name | SARS-CoV-2 and COVID-19 Research |
| related_works | https://openalex.org/W3001590743, https://openalex.org/W2503659988, https://openalex.org/W3015942815, https://openalex.org/W3035443521, https://openalex.org/W2315545909, https://openalex.org/W2906724980, https://openalex.org/W2781372331, https://openalex.org/W2089483435, https://openalex.org/W4362237859, https://openalex.org/W1958497770 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1093/ecco-jcc/jjac190.0665 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2735960814 |
| best_oa_location.source.issn | 1873-9946, 1876-4479 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1873-9946 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Journal of Crohn s and Colitis |
| best_oa_location.source.host_organization | https://openalex.org/P4310311648 |
| best_oa_location.source.host_organization_name | Oxford University Press |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310311648 |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://academic.oup.com/ecco-jcc/article-pdf/17/Supplement_1/i664/48954127/jjac190.0665.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Journal of Crohn's and Colitis |
| best_oa_location.landing_page_url | https://doi.org/10.1093/ecco-jcc/jjac190.0665 |
| primary_location.id | doi:10.1093/ecco-jcc/jjac190.0665 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2735960814 |
| primary_location.source.issn | 1873-9946, 1876-4479 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1873-9946 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Journal of Crohn s and Colitis |
| primary_location.source.host_organization | https://openalex.org/P4310311648 |
| primary_location.source.host_organization_name | Oxford University Press |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310311648 |
| primary_location.license | |
| primary_location.pdf_url | https://academic.oup.com/ecco-jcc/article-pdf/17/Supplement_1/i664/48954127/jjac190.0665.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Journal of Crohn's and Colitis |
| primary_location.landing_page_url | https://doi.org/10.1093/ecco-jcc/jjac190.0665 |
| publication_date | 2023-01-30 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.A | 281 |
| abstract_inverted_index.UK | 60 |
| abstract_inverted_index.WT | 166, 189, 276, 290 |
| abstract_inverted_index.We | 19, 38 |
| abstract_inverted_index.an | 348 |
| abstract_inverted_index.as | 347 |
| abstract_inverted_index.at | 58 |
| abstract_inverted_index.by | 130 |
| abstract_inverted_index.in | 173, 191, 204, 212, 231, 259, 297, 312 |
| abstract_inverted_index.of | 55, 100, 126, 226, 284 |
| abstract_inverted_index.on | 70, 234, 261, 288 |
| abstract_inverted_index.or | 10, 86, 250, 265, 316 |
| abstract_inverted_index.to | 16, 21 |
| abstract_inverted_index.(68 | 43 |
| abstract_inverted_index.1). | 178 |
| abstract_inverted_index.261 | 48 |
| abstract_inverted_index.329 | 41 |
| abstract_inverted_index.GMR | 207 |
| abstract_inverted_index.HCs | 174 |
| abstract_inverted_index.IBD | 24, 63, 176, 213, 232, 329 |
| abstract_inverted_index.IFX | 79, 235, 241 |
| abstract_inverted_index.The | 62, 105 |
| abstract_inverted_index.and | 47, 93, 116, 123, 140, 152, 169, 175, 242, 277, 327 |
| abstract_inverted_index.are | 303, 321 |
| abstract_inverted_index.but | 257 |
| abstract_inverted_index.for | 134 |
| abstract_inverted_index.had | 51 |
| abstract_inverted_index.how | 23 |
| abstract_inverted_index.may | 331 |
| abstract_inverted_index.not | 258 |
| abstract_inverted_index.the | 31, 94, 117, 121, 170, 289, 306 |
| abstract_inverted_index.was | 65, 103, 108, 269, 345 |
| abstract_inverted_index.who | 50 |
| abstract_inverted_index.(GMR | 236, 245, 252 |
| abstract_inverted_index.(HC) | 46 |
| abstract_inverted_index.(WT) | 114 |
| abstract_inverted_index.(fig | 177 |
| abstract_inverted_index.(two | 144 |
| abstract_inverted_index.0.07 | 208 |
| abstract_inverted_index.0.11 | 200 |
| abstract_inverted_index.0.34 | 246 |
| abstract_inverted_index.0.37 | 253 |
| abstract_inverted_index.0.44 | 237 |
| abstract_inverted_index.CI], | 199 |
| abstract_inverted_index.IBD) | 49 |
| abstract_inverted_index.IBD. | 300 |
| abstract_inverted_index.Mean | 195 |
| abstract_inverted_index.[95% | 198 |
| abstract_inverted_index.age. | 141 |
| abstract_inverted_index.both | 165, 192 |
| abstract_inverted_index.dose | 149, 283 |
| abstract_inverted_index.from | 335, 353 |
| abstract_inverted_index.half | 95 |
| abstract_inverted_index.have | 13 |
| abstract_inverted_index.mRNA | 150, 156 |
| abstract_inverted_index.nine | 59 |
| abstract_inverted_index.sera | 102 |
| abstract_inverted_index.than | 186 |
| abstract_inverted_index.that | 218 |
| abstract_inverted_index.type | 139 |
| abstract_inverted_index.were | 91, 183, 228 |
| abstract_inverted_index.with | 3, 271, 299, 323 |
| abstract_inverted_index.& | 78 |
| abstract_inverted_index.(GMR) | 197 |
| abstract_inverted_index.(IBD) | 7 |
| abstract_inverted_index.(IFX) | 75 |
| abstract_inverted_index.Grant | 352 |
| abstract_inverted_index.Ratio | 196 |
| abstract_inverted_index.after | 120, 223 |
| abstract_inverted_index.aimed | 20 |
| abstract_inverted_index.based | 287 |
| abstract_inverted_index.bowel | 5 |
| abstract_inverted_index.doses | 54, 125, 145, 155, 225 |
| abstract_inverted_index.lower | 185, 230, 272, 304, 324 |
| abstract_inverted_index.prior | 135 |
| abstract_inverted_index.spike | 291 |
| abstract_inverted_index.third | 124, 148, 282 |
| abstract_inverted_index.three | 53, 224 |
| abstract_inverted_index.virus | 115, 168, 190 |
| abstract_inverted_index.weeks | 68 |
| abstract_inverted_index.which | 339 |
| abstract_inverted_index.(NT50) | 99 |
| abstract_inverted_index.(n=46) | 85 |
| abstract_inverted_index.(three | 154 |
| abstract_inverted_index.0.08], | 210 |
| abstract_inverted_index.0.15], | 202 |
| abstract_inverted_index.0.77], | 248 |
| abstract_inverted_index.0.92], | 255 |
| abstract_inverted_index.0.97], | 239 |
| abstract_inverted_index.BA.4/5 | 35, 118, 171, 182, 222, 278 |
| abstract_inverted_index.Pfizer | 354 |
| abstract_inverted_index.[0.06, | 209 |
| abstract_inverted_index.[0.09, | 201 |
| abstract_inverted_index.[0.15, | 247, 254 |
| abstract_inverted_index.[0.20, | 238 |
| abstract_inverted_index.adults | 42 |
| abstract_inverted_index.affect | 26 |
| abstract_inverted_index.assays | 90 |
| abstract_inverted_index.boosts | 293 |
| abstract_inverted_index.either | 71 |
| abstract_inverted_index.groups | 193 |
| abstract_inverted_index.models | 216 |
| abstract_inverted_index.second | 122 |
| abstract_inverted_index.showed | 217 |
| abstract_inverted_index.taking | 314 |
| abstract_inverted_index.target | 340 |
| abstract_inverted_index.titres | 163, 180, 296 |
| abstract_inverted_index.(n=23). | 88 |
| abstract_inverted_index.(n=43), | 76, 83 |
| abstract_inverted_index.(n=46), | 81 |
| abstract_inverted_index.(n=60), | 73 |
| abstract_inverted_index.BA.4/5, | 310 |
| abstract_inverted_index.Methods | 37 |
| abstract_inverted_index.Omicron | 34, 341 |
| abstract_inverted_index.Results | 142 |
| abstract_inverted_index.against | 30, 112, 164, 181, 188, 221, 275, 305 |
| abstract_inverted_index.benefit | 334 |
| abstract_inverted_index.disease | 6 |
| abstract_inverted_index.healthy | 44, 205 |
| abstract_inverted_index.maximal | 96 |
| abstract_inverted_index.outcome | 107 |
| abstract_inverted_index.primary | 106 |
| abstract_inverted_index.receive | 332 |
| abstract_inverted_index.support | 344 |
| abstract_inverted_index.therapy | 12 |
| abstract_inverted_index.vaccine | 57, 138, 227, 286, 337 |
| abstract_inverted_index.variant | 119, 309 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.Antibody | 179 |
| abstract_inverted_index.COVID-19 | 17, 56, 285 |
| abstract_inverted_index.However, | 301 |
| abstract_inverted_index.Limited. | 355 |
| abstract_inverted_index.Patients | 2 |
| abstract_inverted_index.Research | 351 |
| abstract_inverted_index.anti-TNF | 9, 315 |
| abstract_inverted_index.antibody | 28, 295 |
| abstract_inverted_index.bivalent | 336 |
| abstract_inverted_index.boosters | 338 |
| abstract_inverted_index.centres. | 61 |
| abstract_inverted_index.controls | 45 |
| abstract_inverted_index.dominant | 33, 308 |
| abstract_inverted_index.patients | 233, 260, 298, 313, 330 |
| abstract_inverted_index.provided | 346 |
| abstract_inverted_index.received | 52 |
| abstract_inverted_index.response | 111 |
| abstract_inverted_index.therapy) | 69 |
| abstract_inverted_index.therapy, | 132 |
| abstract_inverted_index.therapy. | 318 |
| abstract_inverted_index.vaccine) | 151, 157 |
| abstract_inverted_index.vaccine, | 128, 147 |
| abstract_inverted_index.variants | 172 |
| abstract_inverted_index.Financial | 343 |
| abstract_inverted_index.P=0.0098) | 249 |
| abstract_inverted_index.P=0.032), | 256 |
| abstract_inverted_index.P=0.042), | 240 |
| abstract_inverted_index.Sponsored | 350 |
| abstract_inverted_index.adjusting | 133 |
| abstract_inverted_index.currently | 32, 307 |
| abstract_inverted_index.determine | 22 |
| abstract_inverted_index.increased | 161 |
| abstract_inverted_index.infection | 268 |
| abstract_inverted_index.performed | 92 |
| abstract_inverted_index.receiving | 8 |
| abstract_inverted_index.recruited | 40 |
| abstract_inverted_index.responses | 15, 29, 302 |
| abstract_inverted_index.variants. | 36, 342 |
| abstract_inverted_index.wild-type | 113 |
| abstract_inverted_index.(Geometric | 194 |
| abstract_inverted_index.Background | 1 |
| abstract_inverted_index.Conclusion | 280 |
| abstract_inverted_index.SARS-CoV-2 | 167 |
| abstract_inverted_index.additional | 333 |
| abstract_inverted_index.adenovirus | 146 |
| abstract_inverted_index.antibodies | 187, 220, 274, 326 |
| abstract_inverted_index.associated | 270, 322 |
| abstract_inverted_index.attenuated | 14 |
| abstract_inverted_index.ethnicity, | 137 |
| abstract_inverted_index.homologous | 153 |
| abstract_inverted_index.infection, | 136 |
| abstract_inverted_index.infections | 320 |
| abstract_inverted_index.infliximab | 74 |
| abstract_inverted_index.inhibitory | 97 |
| abstract_inverted_index.patients). | 214 |
| abstract_inverted_index.population | 64 |
| abstract_inverted_index.strategies | 159 |
| abstract_inverted_index.stratified | 129 |
| abstract_inverted_index.thiopurine | 72, 77, 243, 262 |
| abstract_inverted_index.treatments | 25 |
| abstract_inverted_index.(&gt;12 | 67 |
| abstract_inverted_index.calculated. | 104 |
| abstract_inverted_index.combination | 80, 244 |
| abstract_inverted_index.established | 66 |
| abstract_inverted_index.participant | 101 |
| abstract_inverted_index.tofacitinib | 87, 251 |
| abstract_inverted_index.ustekinumab | 82, 264 |
| abstract_inverted_index.vaccination | 158 |
| abstract_inverted_index.vedolizumab | 84 |
| abstract_inverted_index.Breakthrough | 267, 319 |
| abstract_inverted_index.Heterologous | 143 |
| abstract_inverted_index.Inflammatory | 4 |
| abstract_inverted_index.Investigator | 349 |
| abstract_inverted_index.glycoprotein | 292 |
| abstract_inverted_index.monotherapy, | 263 |
| abstract_inverted_index.neutralising | 27, 110, 162, 219, 273, 294, 325 |
| abstract_inverted_index.particularly | 311 |
| abstract_inverted_index.vaccination. | 18 |
| abstract_inverted_index.vedolizumab. | 266 |
| abstract_inverted_index.JAK-inhibitor | 11, 317 |
| abstract_inverted_index.Multivariable | 215 |
| abstract_inverted_index.concentration | 98 |
| abstract_inverted_index.participants; | 206 |
| abstract_inverted_index.prospectively | 39 |
| abstract_inverted_index.significantly | 160, 184, 229 |
| abstract_inverted_index.P&lt;0.0001 | 203, 211 |
| abstract_inverted_index.anti-SARS-CoV-2 | 109, 127 |
| abstract_inverted_index.(P&lt;0.05). | 279 |
| abstract_inverted_index.immunosuppressed | 328 |
| abstract_inverted_index.immunosuppressive | 131 |
| abstract_inverted_index.Pseudoneutralisation | 89 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 37 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.7799999713897705 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.01556928 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |